content top

Retinal Fold in Macula After PVR

Read More

Serous Macular Detachment Secondary to Choroidal Osteoma: Inefficacy of Intravitreal Ranibizumab Therapy

Francisco J. Ascaso, Laura Villén, Valentín Huerva, Javier Mateo, María A. Del Buey (Zaragoza, Spain) Advantages: Choroidal osteoma (CO), typically found in healthy young women, is a rare benign intraocular tumor composed of mature cancellous bone replacing the full thickness of the choroid. Vision loss in CO depends on tumor location, serous retinal detachment (RD) associated or not, the presence of choroidal neovascularization (CNV),...

Read More

Suspension Phase Microsphere Immunoassay of Bevacizumab Levels in Ocular Fluids and Sera

Susan J. Wong, PhD (Albany, NY), Paul M. Beer, MD (Albany, NY) PURPOSE: Bevacizumab, a humanized monoclonal antibody targeting VEGF, is currently injected into vitreous humor to treat age-related macular degeneration. proliferative diabetic retinopathy and other conditions associatd with vascular leakage and angiogenesis. We developed a suspension phase microsphere immunoassay of free bevacizumab levels in ocular fluids and serum to enable...

Read More

Combination Therapy of Photodynamic Therapy with Verteporfin and Intravitreal Pegaptanib in the Management of Exudative ARMD

Asheesh Tewari, MD (St. Louis, MO), Rajendra S. Apte, MD, PhD (St. Louis, MO)* PURPOSE: To examine outcomes of a group of previously treatment naïve patients treated with combined photodynamic therapy with verteporfin and intravitreal pegaptanib for choroidal neovascularization secondary to ARMD. METHODS: Retrospective review of ten eyes of ten consecutive patients with CNV secondary to ARMD. These patients had  not received  any prior...

Read More

Intravitreal Bevacizumab (Avastin) Enhanced Pegaptanib (Macugen) Therapy for Choroidal Neovascularization in AMD: An Avastin Booster

http://www.evrs.eu/medias/2006/congress/Intravitreal-Bevacizumab-(Avastin)-Enhanced-Pegaptanib-(Macugen)-Therapy-for-Choroidal-Neovascularization-in-AMD:-An Avastin-Booster.swf Michael J. Tolentino, MD (Winter Haven, FL),* David M. Misch, MD (Winter Haven, FL), Adam S. Berger, MD (Winter Haven, FL), Suk Jin Moon, MD (Winter Haven, Fl) PURPOSE: The study purpose is to determine if bevacizumab combined with pegaptanib can harness the rapid...

Read More

Quality of Life in Patients with Age-related Macular Degeneration: Results from the VI.S.I.O.N. Trial

Manjula Patel, MD (New York, NY),* Jordi Mones, MD (Barcelona, Spain), Anita Leys, PhD, MD (Leuven, Belgium), Gergana Zlateva, PhD (New York, NY),* Sonali N. Shah, BS Pharm, MPH (New York, NY)* PURPOSE: Patients with AMD are more likely to need help with daily activities, experience more emotional distress, and report a reduced quality of life than those without AMD. Pegaptanib sodium is the first pharmacological treatment for subfoveal...

Read More
content top